The aim of this study was to identify the worldwide practice of Cypher Select (Cordis Corporation, Bridgewater, New Jersey) or Cypher Select Plus sirolimus-eluting stent (SES) in patients 80 years of age (octogenarian) and to identify clinical outcomes in this patient population.
Sirolimus-eluting coronary stents in octogenarians: a 1-year analysis of the worldwide e-SELECT Registry / Y.J. Hong, M.H. Jeong, A. Abizaid, A. Banning, A. Bartorelli, V. Dzavik, S.G. Ellis, R. Gao , D.R. Jr Holmes, V. Legrand, F.J. Neumann, C. Spaulding, S. Worthley, P. Urban; e-SELECT Registry Investigators. - In: JACC: CARDIOVASCULAR INTERVENTIONS. - ISSN 1936-8798. - 4:9(2011 Sep), pp. 982-991.
Sirolimus-eluting coronary stents in octogenarians: a 1-year analysis of the worldwide e-SELECT Registry
A. Bartorelli;
2011
Abstract
The aim of this study was to identify the worldwide practice of Cypher Select (Cordis Corporation, Bridgewater, New Jersey) or Cypher Select Plus sirolimus-eluting stent (SES) in patients 80 years of age (octogenarian) and to identify clinical outcomes in this patient population.
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
